Cell Medicine is an open access, peer reviewed journal that publishes research on the subject of cell therapy and its translational application to human diseases. Topics include the use of cells, engineered cells and stem cells derived from a multitude of different sources, covering aspects of physiological, medical, tissue engineering, and device-oriented manipulation of the nervous system, endocrine, cardiac, bone, skin, muscle and other organs, with the ultimate aim of clinical translation are acceptable. To provide complete coverage of this revolutionary field, Cell Medicine reports on relevant technological advances and their potential for translational medicine. Cell Medicine also encompasses other forms of cellular study that are expected to ultimately result in a translational therapy. Rigorous peer review is applied to all articles published in Cell Medicine to ensure only high quality contributions from all areas of translational research are accepted.
Publication in the journal is subject to payment of an article processing charge (APC). The APC serves to support the journal and ensures that articles are freely accessible online in perpetuity under a Creative Commons licence.
The APC for this journal is currently $1500 USD.
The article processing charge (APC) is payable when a manuscript is accepted after peer review, before it is published. The APC is subject to taxes where applicable. Tax-exempt status can be indicated be providing appropriate registration numbers when payment is requested. Please see further details here.
This journal is a member of the Committee on Publication Ethics (COPE).
Cell Medicine features:
Original Contributions: Peer-reviewed, high-quality research investigations that represent new and significant contributions to translational science.
Review Articles: Reviews of major areas in cellular therapy. These may be of any length and are peer reviewed.
Brief Communications and Letters: Timely and brief peer-reviewed studies or reader’s comments on matters of interest or already published articles.
The importance of translating original, peer-reviewed research and review articles on the subject of cell therapy and its application to human diseases has led to the formation of the journal Cell Medicine. Articles may deal with a wide range of topics including physiological, medical, preclinical, tissue engineering, and device-oriented aspects of transplantation of nervous system, endocrine, growth factor-secreting, bone marrow, epithelial, endothelial, and genetically engineered cells, and stem cells, among others. Basic clinical studies and immunological research papers may also be featured if they have a translational interest. To provide complete coverage of this revolutionary field, Cell Medicine will report on relevant technological advances and their potential for translational medicine. Cell Medicine is an online-only, gold open access journal.
|Dragos Cretoiu||Carol Davila University of Medicine and Pharmacy, Romania|
|Koji Abe||Okayama University, Japan|
|Rodolfo Alejandro||University of Miami School of Medicine, USA|
|Federico Bertuzzi||Ospedale Niguarda Cà Granda, Italy|
|Kenneth L. Brayman||University of Virginia Health System, USA|
|Enio Buffolo||Federal University of São Paulo, Brazil|
|Tom Chase||KM Pharmaceutical Consulting, Washington, DC, USA|
|Fu-Chou Cheng||Taichung Veterans General Hospital, Taiwan|
|Tzyy-Wen Chiou||National Dong Hwa University, Taiwan|
|Michael Chopp||Henry Ford Hospital, USA|
|Francesca Cicchetti||CHUL, Canada|
|L. Eduardo Cruz||Cryopraxis, São Paulo, Brazil|
|Robert Deans||Athersys, Cleveland, OH, USA|
|Anil Dhawan||King's College Hospital, UK|
|Wei-Ming Duan||Ohio University, USA|
|Stephen B. Dunnett||Cardiff University, UK|
|Luis Fernandez||H4/782 Clinical Science Center, USA|
|Thomas B. Freeman||University of South Florida, USA|
|Ru-Huei Fu||China Medical University Hospital, Taiwan|
|Craig R. Halberstadt||Tengion, Inc., USA|
|Joshua Hare||University of Miami, USA|
|Horng-Jyh Harn||China Medical University Hospital, Taiwan|
|Nelson A. Hossne, Jr.||Federal University of São Paulo, Brazil|
|Hongyun Huang||Beijing Hongtianji Neuroscience Academy, China|
|Johnny Huard||Steadman Philippon Research Institute, USA|
|Dixon B. Kaufman||Northwestern University Medical School, USA|
|Jonathan Lakey||University of California Irvine, USA|
|Jian Lin||XBiotech, Austin, TX, USA|
|Shinn-Zong Lin||Tzu Chi University, Taiwan|
|Gele Liu||Carleton University, Canada|
|Shih-Ping Liu||China Medical University, Taiwan|
|Walter Low||University of Minnesota, USA|
|Agnes Luo||Case Western Reserve University, USA|
|Daniela Moraes||University of São Paulo, Brazil|
|Keita Mori||SanBio, Mountain Valley, CA, USA|
|Guido Nikkhah||Albert-Ludwigs-University, Germany|
|Andreas Nüssler||University of Tübingen, Germany|
|Kazuo Ohashi||Tokyo Women's Medical University, Japan|
|Michael Ott||Hannover Medical School, Germany|
|Amit Patel||University of Miami School of Medicine, USA|
|Marc S. Penn||Summa Cardiovascular Institute, USA|
|Camillo Ricordi||University of Miami, USA|
|Maria Carolina Oliveira Rodrigues||University of São Paulo, Brazil|
|Warren Sherman||Columbia University, USA|
|John Sinden||ReNeuron, UK|
|John R. Sladek||University of Colorado, USA|
|Evan Y. Snyder||Burnham Institute for Medical Research, USA|
|Kwok-Fai So||University of Hong Kong, Hong Kong|
|Etienne M. Sokal||Université Catholique de Louvain, Belgium|
|Myron Spector||VA Boston Healthcare System, USA|
|Christof Stamm||Deutches Herzzentrum Berlin, Germany|
|Stephen Strom||Karolinska Institute, Sweden|
|Hong-Lin Su||National Chung Hsing University, Taiwan|
|Jacques P. Tremblay||CHUL, Canada|
|Wise Young||Rutgers State University of New Jersey, USA|
|Andrew Zeitlin||Celgene Cellular Therapeutics, Warren, NJ, USA|
This Journal is a member of the Committee on Publication Ethics.
This Journal recommends that authors follow the Uniform Requirements for Manuscripts Submitted to
Biomedical Journals formulated by the International Committee of Medical Journal Editors (ICMJE).
Please read the guidelines below then visit the journal’s submission site https://mc.manuscriptcentral.com/cellmedicine to upload your manuscript. Please note that manuscripts not conforming to these guidelines may be returned.
Only manuscripts of sufficient quality that meet the aims and scope of Cell Medicine will be reviewed.
As part of the submission process you will be required to warrant that you are submitting your original
work, that you have the rights in the work, that you are submitting the work for first publication in the Journal and that it is not being considered for publication elsewhere and has not already been published elsewhere, and that you have obtained and can supply all necessary permissions for the reproduction of any copyright works not owned by you.
Please include a cover letter, containing the name, full mailing address, telephone, email address and fax number (if applicable) of the author responsible for correspondence. Follow the Preparing Your Manuscript (section 6) guidelines below to prepare the manuscript, figures, and tables.
Please read the Manuscript Submission Guidelines below before submitting your manuscript here:
- Open Access
- Article processing charge (APC)
- What do we publish?
3.1 Aims & scope
3.2 Article types
3.3 Writing your paper
3.3.1 Making your article discoverable
- Editorial policies
4.1 Peer Review Policy
4.3.1 Writing Assistance
4.5 Declaration of conflicting interests
4.6 Research ethics and patient consent
4.6.1 Use of Animal - and Human - derived tissue
4.7 Clinical Trials
4.8 Reporting guidelines
- Publishing policies
5.1 Publication ethics
5.1.2 Prior publication
5.2 Contributor's publishing agreement
- Preparing your manuscript
6.1 Word processing formats
6.2 Artwork, figures and other graphics
6.3 Supplementary material
6.4 Reference style
6.5 English language editing services
- Submitting your manuscript
7.1 How to submit your manuscript
7.2 Title, keywords and abstracts
7.3 Information required for completing your submission
7.3.1 Corresponding author contact details
- On acceptance and publication
8.1 SAGE Production
8.2 Continuous publication
8.3 Promoting your article
- Further information
Cell Medicine is an open access, peer-reviewed journal. Each article accepted by peer review is made freely available online immediately upon publication, is published under a Creative Commons license and will be hosted online in perpetuity. Publication costs of the journal are covered by the collection of article processing charges which are paid by the funder, institution or author of each manuscript upon acceptance. There is no charge for submitting a paper to the journal.
If, after peer review, your manuscript is accepted for publication, a one-time article processing charge (APC) is payable. This APC covers the cost of publication and ensures that your article will be freely available online in perpetuity under a Creative Commons license.
At the time of submission you will be asked to confirm that you will pay the open access fees when billed.
The current APC is $1,400 USD / £935 GBP. As of 1st July 2018, the APC will increase to $1500 USD (plus tax where applicable). The APC is based on the date of original peer review submission.
Before submitting your manuscript to Cell Medicine, please ensure you have read the Aims & Scope.
On the first page should be the abstract (a maximum of 300 words) and 4-6 keywords. All tables should be placed at the end of the file and numbered in the order they appear in the text. We strongly encourage the appropriate use of bar charts and line graphs to illustrate key findings. Figures should be placed in individual files (we accept TIFF, JPEG, and eps), separate from the main document file.
Article types published by Cell Medicine are given below; certain article types observe limits on words and in-text tables. Please see below. Word limits include tables, but not abstracts, key words, or references.
- Original Research– Peer-reviewed, high-quality research investigations that represent new and significant contributions to science.
- Reviews– Reviews of major areas in cellular medicine. These may be of any length, may include figures (schematics) and are peer reviewed.
- Brief Communications – Timely and brief peer-reviewed studies.
- Maximum of two tables or two figures (or one table and one figure). Maximum page limit is 5 pages once typeset, not including the reference list.
- Case Studies
- Editorials/Letters to the Editor– Editor’s opinion or insight on a topic/ Readers' comments on journal articles and other matters of interest to transplant researchers.
- Announcements and News – Notices of upcoming meetings, conferences, seminars, and other events of interest to those in the field.
- Commentary– May be for responses to published papers, responses to other comments, opinion pieces on new or old important topics in the field, etc.
Editorials and Commentaries will not be charged an APC.
All article types require a structured abstract except commentaries, which include a summary.
Cell Medicine uses the Council of Science Editors (citation-sequence) style for formatting citations and the reference list.
The SAGE Author Gateway has some general advice and on how to get published, plus links to further resources.
When writing up your paper, think about how you can make it discoverable. The title, keywords and abstract are key to ensuring readers find your article through search engines such as Google. For information and guidance on how best to title your article, write your abstract and select your keywords, have a look at this page on the Gateway: How to Help Readers Find Your Article Online
Following a preliminary triage to eliminate submissions unsuitable for Cell Medicine, all papers are sent out for review.
The journal’s policy is to have manuscripts reviewed by two expert reviewers. Cell Medicine utilizes a single- blind peer review process in which the reviewer’s names and information is withheld from the author.
Reviewers are expected to not possess any conflicts of interest with the authors and research. They should review the science objectively and provide recommendations for improvements where necessary. When aware of relevant published work not being cited, the reviewers should recommend inclusion of these references. If the reviewer feels that they would be unable to repeat the study as described, then additional methodological details should be requested. Any unpublished information read by a reviewer should be treated as confidential.
All manuscripts are reviewed as rapidly as possible, while maintaining rigor. Peer review is managed by the Cell Medicine Editorial Office Peer who assigns each submitted manuscript to appropriate reviewers and, with the input of the Editorial Board, and comments and recommendations of the reviewers, makes decisions on the eligibility of the article for publication.
Papers should only be submitted for consideration once consent is given by all contributing authors. Those submitting papers should carefully check that all those whose work contributed to the paper are acknowledged as contributing authors.
The list of authors should include all those who can legitimately claim authorship. This is all those who:
(i) Made a substantial contribution to the concept or design of the work; or acquisition, analysis or interpretation of data,
(ii) Drafted the article or revised it critically for important intellectual content,
(iii) Approved the version to be published,
(iv) Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content.
Authors should meet the conditions of all of the points above. Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content.
When a large, multicentre group has conducted the work, the group should identify the individuals who accept direct responsibility for the manuscript. These individuals should fully meet the criteria for authorship.
Acquisition of funding, collection of data, or general supervision of the research group alone does not constitute authorship, although all contributors who do not meet the criteria for authorship should be listed in the Acknowledgments section. Please refer to the International Committee of Medical Journal Editors (ICMJE) authorship guidelines for more information on authorship.
The reported research must be novel and authentic and the authors should confirm that the same data has not been and is not going to be submitted to another journal (unless already rejected). Statements made in the introduction and discussion should be supported by appropriate references and sufficient experimental detail should be provided to allow for repetition of the study by another group. Plagiarism of the text/data will not be tolerated and could result in retraction of an accepted article. Any text or figures reproduced for another source require the permission of the original copyright holders (normally the publishers).
Any manipulation of figures should be equally applied and described in the text including pseudo-coloring and must not change the meaning of the figure.
When humans, animals or tissue derived from them have been used, then mention of the appropriate ethical approval must be included in the manuscript.
All contributors who do not meet the criteria for authorship should be listed in an Acknowledgements section. Examples of those who might be acknowledged include a person who provided purely technical help, or a department chair who provided only general support.
Financial support and conflicts of interest for all authors must be declared. Further information on this can be obtained from the International Committee for Medical Journal Editors (http://www.icmje.org/).
Please acknowledge any funding support. In addition, all authors need to disclose any conflicts of interest, financial or otherwise, in a separate section before the references. Conflicts of interest may include:
1. Direct ownership of equity or shares in a health care or pharmaceutical company relating to the manuscript, by any author or their immediate family members.
2. Receipt of any form of income by any author or their immediate family members from health care or pharmaceutical companies related to the manuscript within the calendar year preceding original submission.
3. Personal interest such as being an expert witness, public advocate, grantee, consultant, founder, owner, or employee of a health care or pharmaceutical company related to the research.
Individuals who provided writing assistance, e.g. from a specialist communications company, do not qualify as authors and so should be included in the Acknowledgements section. Authors must disclose any writing assistance – including the individual’s name, company and level of input – and identify the entity that paid for this assistance.
It is not necessary to disclose use of language polishing services.
Any acknowledgements should appear first at the end of your article prior to your Declaration of Conflicting Interests (if applicable), any notes and your References.
Cell Medicine requires all authors to acknowledge their funding in a consistent fashion under a separate heading. Please visit the Funding Acknowledgements page on the SAGE Journal Author Gateway to confirm the format of the acknowledgment text in the event of funding, or state that: This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
It is the policy of Cell Medicine to require a declaration of conflicting interests from all authors enabling a statement to be carried within the paginated pages of all published articles.
Please ensure that a ‘Declaration of Conflicting Interests’ statement is included at the end of your manuscript, after any acknowledgements and prior to the references. If no conflict exists, please state that ‘The Author(s) declare(s) that there is no conflict of interest’.
In addition, there are sections for detailing any conflicts of interest and financial support and that you (as corresponding/submitting author) have the permission of the other authors to submit the manuscript.
For guidance on conflict of interest statements, please see the ICMJE recommendations.
Medical research involving human subjects must be conducted according to the World Medical
Association Declaration of Helsinki.
Submitted manuscripts should conform to the ICMJE Recommendations for the Conduct,
Reporting, Editing, and Publication of Scholarly Work in Medical Journals.
All papers reporting animal and/or human studies must state in both the Methods section and in the ethical statements (following the Conclusion, before the References) that the relevant Ethics Committee, Institutional Review Board (IRB), or Institutional Animal Care and Use Committee (IACUC) provided (or waived) approval. Please ensure that you have provided the full name and institution of the review committee, in addition to the approval number.
- Please address the following statements. Please refer to the sample statements in this template (Word doc) to help you decide which statement is applicable for your work. Include these at the end of your manuscript directly in the document.
- Ethical Approval
- Statement of Human and Animal Rights
- Statement of Informed Consent
- For research articles, case reports, and other relevant articles, authors are required to state whether participants provided informed consent for patients information and images to be published and whether the consent was written or verbal or provided by a legally authorized representative.
Please also refer to the ICMJE Recommendations for the Protection of Research Participants
Please confirm within the text that the appropriate ethical and/or regulatory body approved the use of animal- or human-derived tissue (as well as informed consent for humans). With human derived data, articles are published on the understanding that appropriate measures to protect the privacy of the individuals were undertaken.
Cell Medicine conforms to the ICMJE requirement that clinical trials are registered in a WHO approved public trials registry at or before the time of first patient enrolment as a condition of consideration for publication. The trial registry name and URL, and registration number must be included at the end of the abstract.
The relevant EQUATOR Network reporting guidelines should be followed depending on the type of study. For example, all randomized controlled trials submitted for publication should include a completed CONSORT flow chart as a cited figure and the completed CONSORT checklist should be uploaded with your submission as a supplementary file. Systematic reviews and metaanalyses should include the completed PRISMA flow chart as a cited figure and the completed PRISMA checklist should be uploaded with your submission as a supplementary file. The EQUATOR wizard can help you identify the appropriate guideline.
Other resources can be found at NLM’s Research Reporting Guidelines and Initiatives.
SAGE is committed to upholding the integrity of the academic record. We encourage authors to refer to the Committee on Publication Ethics’ International Standards for Authors and view the Publication Ethics page on the SAGE Author Gateway.
Cell Medicine and SAGE take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. We seek to protect the rights of our authors and we always investigate claims of plagiarism or misuse of published articles. Equally, we seek to
protect the reputation of the journal against malpractice. Submitted articles may be checked with duplication-checking software. Where an article, for example, is found to have plagiarized other work or included third-party copyright material without permission or with insufficient acknowledgement, or here the authorship of the article is contested, we reserve the right to take action including, but not limited to: publishing an erratum or corrigendum (correction); retracting the article; taking up the matter with the head of department or dean of the author's institution and/or relevant academic bodies or societies; or taking appropriate legal action.
If material has been previously published, it is not generally acceptable for publication in a SAGE journal. However, there are certain circumstances where previously published material can be considered for publication. Please refer to the guidance on the SAGE Author Gateway or if in doubt, contact the Editor at the address given below.
Before publication SAGE requires the author as the rights holder to sign a Journal Contributor’s Publishing Agreement. Cell Medicine publishes manuscripts under Creative Commons licenses.
The standard license for the journal is Creative Commons by Attribution Non-Commercial (CC BY-NC), which allows others to re-use the work without permission as long as the work is properly referenced and the use is non-commercial. For more information, you are advised to visit SAGE's OA licenses page.
Alternative license arrangements are available, for example, to meet particular funder mandates, made at the author’s request.
Preferred formats for the text and tables of your manuscript are Word DOC, RTF, XLS. Papers should be typed in English, double-spaced throughout with at least 3-cm margins on paper approximately 22 ´ 28 cm (8 1/2 ´ 11 in.) in size. Please consult the most recent issue of the journal for style and format. Number all pages consecutively, beginning with the title page. Use metric units of measure; other units may be given in parentheses. Typically, only three levels of headings are recognized. The paper should be organized as follows.
Title Page: The title should be brief and specific. The title page should contain, in the following order: title, name(s) and affiliation(s) of author(s) including city, state, postal code, and country, and a suggested running head of not more than 50 characters and spaces. Also indicate which author will be the corresponding author (i.e., to whom correspondence should be addressed, with complete mailing address, telephone and fax numbers, and e-mail necessary for sending proofs). In general, no more than two shared first and/or senior authorships can be considered and they must be appropriately justified in the letter to the editor at the time of submission. The rule can be reassessed on a case-by-case basis for manuscripts arising from multicenter collaborations, but please note that the production office will not liaise with more than two corresponding authors. In the case of two corresponding authors, the proof will only be sent to the first mentioned corresponding author.
Abstract: An abstract of 300 words or less should begin on page 2. It should contain a concise summary of the results, conclusions, and other significant points in the review.
Key words: For the purpose of subject indexing, provide four to six keywords immediately following the abstract.
Text: Every effort should be made to avoid jargon, to spell out all nonstandard abbreviations the first time they are used, and to present the contents of the study as clearly and concisely as possible. In the Materials and Methods section, authors are required to supply sufficient detail for replication of the study, including the name of the company from which the materials (reagents and equipment) were supplied and the location of company headquarters (city, state if in the U.S., and country). References to previously described methods must be properly cited and also described in moderate detail. References should be given for all discussions and conclusions of previous studies. Trade names may appear in parentheses and should be capitalized. Critical discussions of the literature are preferred more than historically oriented information.
Tables: All tables must be created in Microsoft Word. Tables should be numbered and cited sequentially in the text. Prepare each table as a separate page at the end of the manuscript text, after the references. Avoid very wide or long tables that would not fit a printed page. Each table should have a title, and each column in the table should have a brief heading. Define all abbreviations in the table footnote at the bottom of the table.
Figures: Figures should be numbered and cited sequentially in the text. Each figure should be provided as a separate file (see Final Accepted Manuscript). Include all parts of a figure (e.g., A, B, etc.) as one file. Do not use light lettering and shading that will not reproduce well. Figure dimensions and scaling should be suitable for reduction (if necessary) to fit column or page size. Care must be taken that letters and other symbols do not become so small that they are illegible when the figure is reduced. Complex formulas should be prepared as illustrations. (Do not embed figures within the manuscript text.
Figure Legends: Each figure legend must have a short title that concisely describes the content of each figure. List all figure legends sequentially on one or more pages at the end of the manuscript text, after the references, and identify all symbols used in the figures. The figure legend should be as clear as possible and should fully describe the contents of the figure. (Do not include the figure legend as part of the figure). If the figure is from a previously published article, indicate that permission has been obtained from the original publisher.
Figure Files: Each figure should be provided as a separate, high-resolution file. Simple black and white figures (e.g., line graphs, bar graphs, etc.) should be 1200 dpi. Halftone and color figures (or combo figures) should be 600 dpi. Final figure files should be submitted as tiff, jpg, or eps format. Do not include the figure number as part of the figure file (e.g., do not label Figure 1, etc., as part of the figure). Do not provide color in a figure file unless the figure will be published in color.
This journal is able to host additional materials online (e.g. datasets, podcasts, videos, images etc) alongside the full-text of the article. These will be subjected to peer-review alongside the article. For more information please refer to our guidelines on submitting supplementary files, which can be found within our Manuscript Submission Guidelines page.
Literature cited should be prepared according to the Council of Science Editors format (citationsequence) style. This format is conveniently in Endnote and the output style is available at the
following site: http://endnote.com/downloads/style/cse-style-manual-7th-ed-citation-sequ.... Some examples are provided below. References in the text should be cited by superscript number separated by a comma and listed in numerical order as they appear in the text (double spaced) on a separate page at the end of the manuscript. Journal citations in the reference list should contain the following: (a) reference number NOT in superscript; (b) surnames and initials of all authors (surnames precede initials); (c) title of article; (d) journal title abbreviated as listed in ISSN.org; (e) year; volume, inclusive pages. See the examples shown and refer to Council of Science Editors format for more examples.
Journal Article: Wang Y, Nathanson L, McNiece IK. Differential hematopoietic supportive potential and gene expression of stroma cell lines from midgestation mouse placenta and adult bone marrow. Cell Transplant. 2011;20:707–26.
Book Article/Chapter: Taylor MJ, Baicu, S. Hypothermic perfusion of pancreas: Emphasis on preservation prior to islet isolation. In: Uygun K, Lee CY, editors. Organ preservation and reengineering. Boston (MA): Artech House Publisher; 2011. p. 85-104.
Book: Wang-Fischer Y. Manual of stroke models in rats, 1st ed. Boca Raton (FL): CRC Press; 2009.
Internet Source: Stem Cell Research Oversight Committee. University of Wisconsin-Madison policy for multisite research studies using human pluripotent stem cells [Internet]. Madison (WI): University of Wisconsin-Madison; 2009 [cited 2013 Sep 12]. Available from http://www.grad.wisc.edu/admin/committees/scro/documents/Multisiteresear...
An example of an in-text citation is shown below.
Traumatic life events and posttraumatic stress disorder (PTSD) are endemic among American
To cite multiple sources, all numbers associated with the reference being cited should be superscript, separated by a comma, with no spaces between them.
Statistics: If statistical analysis was performed, define the tests used in the methods and ensure that it is clear what comparisons are made. Please ensure that appropriate testing was performed when multiple comparisons (i.e., one group compared to more than one other group) were made.
Manuscripts should be grammatically correct and completely comprehendible upon submission before they will be forwarded for peer review.
Authors seeking assistance with English language editing, translation, or figure and manuscript formatting to fit the journal’s specifications should consider using SAGE Language Services. Visit SAGE Language Services on our Journal Author Gateway for further information.
Cell Medicine is hosted on SAGE Track, a web based online submission and peer review system powered by ScholarOne™ Manuscripts. Visit https://mc.manuscriptcentral.com/cellmedicine to login and submit your article online.
IMPORTANT: Please check whether you already have an account in the system before trying to create a new one. If you have reviewed or authored for the journal in the past year it is likely that you will have had an account created. For further guidance on submitting your manuscript online please visit ScholarOne Online Help.
Please supply a title, short title, an abstract and keywords to accompany your article. The title, keywords and abstract are key to ensuring readers find your article online through online search engines such as Google. Please refer to the information and guidance on how best to title your article, write your abstract and select your keywords by visiting the SAGE Journal Author Gateway for guidelines on How to Help Readers Find Your Article Online.
Provide full contact details for the corresponding author including email, mailing address and telephone numbers. Academic affiliations are required for all co-authors. These details should be presented separately to the main text of the article to facilitate anonymous peer review.
You will be asked to provide contact details and academic affiliations for all co-authors via the submission system and identify who is to be the corresponding author. These details must match what appears on your manuscript. At this stage please ensure you have included all the required statements and declarations and uploaded any additional supplementary files (including reporting guidelines where relevant).
Provide full contact details for the corresponding author including email, mailing address and telephone numbers. Academic affiliations are required for all co-authors. These details should be presented separately to the main text of the article to facilitate anonymous peer review.
As part of our commitment to ensuring an ethical, transparent and fair peer review process SAGE is a supporting member of ORCID, the Open Researcher and Contributor ID. ORCID provides a persistent digital identifier that distinguishes researchers from every other researcher and, through integration in key research workflows such as manuscript and grant submission, supports automated linkages between researchers and their professional activities ensuring that their work is recognized.
We encourage all authors to add their ORCIDs to their SAGE Track accounts and include their ORCIDs as part of the submission process. If you don’t already have one you can create one here.
Authors are responsible for obtaining permission from copyright holders for reproducing any illustrations, tables, figures or lengthy quotations previously published elsewhere. For further information including guidance on fair dealing for criticism and review, please visit our Frequently Asked Questions on the SAGE Journal Author Gateway.
If your paper is accepted for publication after peer review, you will first be asked to complete the contributor’s publishing agreement and pay the current article processing charge (APC) via a payment link. All material accepted for publication is subject to copyediting. Authors will receive page proofs of articles before publication. Please note that no production work will occur on your paper until the APC has been received.
When your paper enters the SAGE Production system, your paper will be issued with a 6 digit ID number. Your SAGE Production Editor will keep you informed as to your article’s progress throughout the production process. Proofs will be sent by PDF to the corresponding author and should be returned promptly. Authors are reminded to check their proofs carefully to confirm that all author information, including names, affiliations, sequence and contact details are correct, and that Funding and Conflict of Interest statements, if any, are accurate. Please note that if there are any changes to the author list at this stage all authors will be required to complete and sign a form authorizing the change.
One of the many benefits of publishing your research in an open access journal is the speed to publication. With no page count constraints, your article will be published online in a fully citable form with a DOI number as soon as it has completed the production process. At this time it will be completely free to view and download for all.
Publication is not the end of the process! You can help disseminate your paper and ensure it is as widely read and cited as possible. The SAGE Author Gateway has numerous resources to help you promote your work. Visit the Promote Your Article page on the Gateway for tips and advice. In addition, SAGE is partnered with Kudos, a free service that allows authors to explain, enrich, share, and measure the impact of their article. Find out how to maximize your article’s impact with Kudos.
Please direct any enquiries about both Cell Transplantation and Cell Medicine to firstname.lastname@example.org